First Experimental Vaccine For Ebola Virus Arrives Liberia

 The first batch of an experimental Ebola vaccine has been shipped to West Africa, destined to help protect 30,000 people in Liberia. The shipment, of an initial 300 vials of the vaccine, marks the first to arrive in one of the three countries worst affected by the Ebola epidemic. 

The drug will form the basis of the first large-scale vaccine trial, with healthcare workers on the front line treating Ebola patients, among the first to receive the drug. 

Researchers hope to enrol up to 30,000 people to take part in the trial, a third of whom will get the vaccine, developed by GlaxoSmithKline.